Addressing Individual Clinicians’ Needs Improves Management of Tardive Dyskinesia
A short educational activity on tardive dyskinesia significantly improved clinicians’ confidence in managing and choosing therapies.
Read MoreFeb 13, 2025
A short educational activity on tardive dyskinesia significantly improved clinicians’ confidence in managing and choosing therapies.
Read MoreFeb 1, 2025
A collection of feature articles, study abstracts, and other resources all focused on tardive dyskinesia.
Read MoreJan 31, 2025
Valbenazine and vitamin E are the most effective treatments for tardive dyskinesia, with valbenazine showing the strongest effect size in recent studies.
Read MoreNov 1, 2024
As this year is nearing the end, PW recaps some of the research presented tardive dyskinesia in 2024.
Read MoreOct 16, 2024
Transcranial direct current stimulation shows potential as an effective, safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia.
Read MoreOct 3, 2024
While uncommon, vocal cord dysfunction related to tardive dyskinesia can occur and may be life-threatening.
Read MoreSep 19, 2024
Patients and physicians agreed that tardive dyskinesia caused significant work impairment, with some patients completely unable to obtain or maintain a job.
Read MoreSep 9, 2024
Recent research published in 2024 examined various tardive dyskinesia topics, including: transcranial direct current stimulation; new clinical tool for documenting and rating TD; and schizophrenia-associated genetic markers.
Read MoreMay 15, 2024
Researchers analyzed whether valbenazine’s impact on tardive dyskinesia symptoms varied between patients with schizophrenia versus bipolar disorder.
Read More